Cobenfy 50 mg/1 (Xanomeline and Trospium Chloride CAPSULE, COATED PELLETS) 50 mg/1

Cobenfy 50 mg/1 combines xanomeline and trospium chloride for therapeutic use. This oral medication is designed to address specific health conditions with a dual-action approach.

Strength

50 mg/1

Pack Size

60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-0050-60)

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cobenfy 50 mg/1 is primarily used for managing symptoms related to certain neurological and urinary conditions. The combination of xanomeline and trospium chloride targets specific receptors to provide relief. People often ask, 'What is Cobenfy used for?' It is typically prescribed for conditions that require both neurological and urinary symptom management.

Side Effects

Common effects of Cobenfy 50 mg/1 may include drowsiness, dry mouth, and blurred vision. Some users might experience gastrointestinal discomfort. These effects can vary based on individual tolerance and dosage.

Precautions & Warnings

Handle Cobenfy 50 mg/1 with care, especially if you have pre-existing conditions like glaucoma or urinary retention. Always follow the guidance of a healthcare professional regarding administration and storage. Keep out of reach of children and pets.

Avoid Interactions

Cobenfy 50 mg/1 may interact with alcohol, antihistamines, and certain antidepressants. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Always consult a professional before combining with other treatments.

Frequently Asked Questions

Cobenfy 50 mg/1 is used to manage symptoms related to certain neurological and urinary conditions. It combines xanomeline and trospium chloride for a dual-action approach.

Cobenfy 50 mg/1 is taken orally, typically as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions.

Common side effects may include drowsiness, dry mouth, and blurred vision. Some users might experience gastrointestinal discomfort.

It is generally advised to avoid alcohol while taking Cobenfy 50 mg/1, as it may increase the risk of side effects. Consult a healthcare professional for personalized advice.

The safety of long-term use of Cobenfy 50 mg/1 should be discussed with a healthcare professional. Regular monitoring may be required.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.